This is in line with previous observations of generalized absence epilepsy (8, 22–26), refractory focal epilepsy or developmental and epileptic encephalopathy (8, 21, 27) in patients with heterozygous CACNA1A loss-of-function pathogenic variants. This evidence concerns the gene CACNA1A and focal epilepsy.